Richard Anderson
Stock Analyst at Wedbush
(3.90)
# 688
Out of 4,761 analysts
139
Total ratings
65.71%
Success rate
5.74%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTR Ventas | Maintains: Outperform | $69 → $78 | $66.85 | +16.68% | 7 | Feb 14, 2025 | |
| DOC Healthpeak Properties | Maintains: Outperform | $24 → $27 | $19.77 | +36.57% | 3 | Feb 14, 2025 | |
| WELL Welltower | Upgrades: Outperform | $145 → $167 | $150.32 | +11.10% | 5 | Feb 14, 2025 | |
| SAFE Safehold | Reiterates: Neutral | $20 → $19 | $16.81 | +13.03% | 4 | Feb 7, 2025 | |
| UMH UMH Properties | Reiterates: Neutral | $20 | $17.64 | +13.38% | 4 | Jan 13, 2025 | |
| STRW Strawberry Fields REIT | Initiates: Outperform | $12 | $11.77 | +1.95% | 1 | Jan 6, 2025 | |
| DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $16.52 | +27.12% | 2 | Jan 2, 2025 | |
| HR Healthcare Realty Trust | Downgrades: Underperform | $18 → $16 | $16.58 | -3.50% | 8 | Jan 2, 2025 | |
| CTRE CareTrust REIT | Downgrades: Underperform | $34 → $26 | $25.62 | +1.48% | 2 | Jan 2, 2025 | |
| BXP BXP, Inc. | Downgrades: Underperform | $81 → $70 | $69.57 | +0.62% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $30.76 | +7.28% | 3 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $65.07 | +10.65% | 1 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $95.52 | +15.16% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $179.66 | +16.33% | 5 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $34.61 | +15.57% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $120.84 | +8.41% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $71.66 | +4.66% | 5 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $294.41 | +2.24% | 8 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $43.01 | +13.93% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $35.13 | +28.10% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $26.73 | +23.46% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $160.08 | +14.94% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $16.76 | +31.26% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $13.03 | +30.47% | 3 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $49.39 | +3.26% | 2 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $55.77 | -12.14% | 5 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $40.78 | +10.35% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $66.82 | +0.27% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $66 | $69.76 | -5.39% | 3 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $3.11 | +141.16% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $103.64 | -9.30% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $12.28 | +14.01% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $16.39 | -2.38% | 5 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $36.17 | -6.00% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $219.38 | -18.41% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.62 | - | 2 | May 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $8.98 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $34.48 | - | 6 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.96 | - | 2 | Jul 10, 2017 |
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $66.85
Upside: +16.68%
Healthpeak Properties
Feb 14, 2025
Maintains: Outperform
Price Target: $24 → $27
Current: $19.77
Upside: +36.57%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $150.32
Upside: +11.10%
Safehold
Feb 7, 2025
Reiterates: Neutral
Price Target: $20 → $19
Current: $16.81
Upside: +13.03%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $17.64
Upside: +13.38%
Strawberry Fields REIT
Jan 6, 2025
Initiates: Outperform
Price Target: $12
Current: $11.77
Upside: +1.95%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $16.52
Upside: +27.12%
Healthcare Realty Trust
Jan 2, 2025
Downgrades: Underperform
Price Target: $18 → $16
Current: $16.58
Upside: -3.50%
CareTrust REIT
Jan 2, 2025
Downgrades: Underperform
Price Target: $34 → $26
Current: $25.62
Upside: +1.48%
BXP, Inc.
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $69.57
Upside: +0.62%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $30.76
Upside: +7.28%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $65.07
Upside: +10.65%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $95.52
Upside: +15.16%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $179.66
Upside: +16.33%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $34.61
Upside: +15.57%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $120.84
Upside: +8.41%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $71.66
Upside: +4.66%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $294.41
Upside: +2.24%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $43.01
Upside: +13.93%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $35.13
Upside: +28.10%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $26.73
Upside: +23.46%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $160.08
Upside: +14.94%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $16.76
Upside: +31.26%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $13.03
Upside: +30.47%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $49.39
Upside: +3.26%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $55.77
Upside: -12.14%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $40.78
Upside: +10.35%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $66.82
Upside: +0.27%
Mar 18, 2024
Maintains: Outperform
Price Target: $64 → $66
Current: $69.76
Upside: -5.39%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $3.11
Upside: +141.16%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $103.64
Upside: -9.30%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $12.28
Upside: +14.01%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $16.39
Upside: -2.38%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $36.17
Upside: -6.00%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $219.38
Upside: -18.41%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $4.62
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $8.98
Upside: -
Nov 2, 2017
Upgrades: Buy
Price Target: n/a
Current: $34.48
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.96
Upside: -